SCHEMBL17309302

SCHEMBL17309302

COc1ccc(CN(c2ncns2)S(=O)(=O)c2ccc(Oc3ccc(-c4cccc(C(F)(F)F)c4)cc3-c3ccnc(CO)c3)c(C#N)c2)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 0.57
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
SCN5A Q14524 2/20 0.50
CYP2C8 P10632 1/20 0.50
CYP2D6 P10635 1/20 0.50
SLC6A2 P23975 1/20 0.50
ADORA1 P30542 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGS2 P35354 1/20 0.50
SCN1A P35498 1/20 0.50
SCN4A P35499 1/20 0.50
SCN7A Q01118 1/20 0.50
SLC6A3 Q01959 1/20 0.50
KCNH2 Q12809 1/20 0.50
SCN2A Q99250 1/20 0.50
SLC5A7 Q9GZV3 1/20 0.50
SCN3A Q9NY46 1/20 0.50
SCN8A Q9UQD0 1/20 0.50
SCN10A Q9Y5Y9 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17293709 0.93 SCN9A (0.56) SCN9ACYP3A4CYP2C9SCN5ACYP2C8
SCHEMBL1690549 0.91 SCN9A (0.54) SCN9ACYP3A4CYP2C9SCN5ACYP2C8
SCHEMBL17309248 0.91 SCN9A (0.54) SCN9ACYP3A4CYP2C9SCN5ACYP2C8
SCHEMBL19398414 0.87 SCN9A (0.46) SCN9ACYP3A4CYP2C9SCN5ACYP2C8
SCHEMBL19379429 0.86 SCN9A (0.49) SCN9ACYP3A4CYP2C9SCN5ACYP2C8
SCHEMBL322600 0.86 SCN9A (0.55) SCN9ACYP3A4CYP2C9SCN5A
SCHEMBL1094068 0.85 SCN9A (0.60) SCN9ACYP3A4CYP2C9SCN5A
SCHEMBL1690606 0.83 SCN9A (0.50) SCN9ACYP3A4CYP2C9SCN5A
SCHEMBL1094099 0.83 SCN9A (0.44) SCN9ACYP3A4CYP2C9SCN5A
SCHEMBL17293838 0.83 SCN9A (0.47) SCN9ACYP3A4CYP2C9SCN5ACYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275275-A1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER (US) 2017-09-28 US disclosed
US-20170275275-A1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER (US) 2017-09-28 US disclosed
WO-2015181797-A1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER INC. (US) 2015-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275275-A1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS SCN7A, SCN1A, SCN2B SCN9A 13/4885CYP3A4 1302/4885CYP2C9 747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.